BoneSupport AB - Company Profile
Powered by 
All the data and insights you need on BoneSupport AB in one report.
$295
- Save hours of research time and resources with
our up-to-date BoneSupport AB Strategy Report
- Understand BoneSupport AB position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is an orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; disease or related to surgical procedures. The company develops its bone graft substitutes using its patented technology platform CERAMENT. Its major products include bone void filler and vancomycin-eluting synthetic bone substitutes. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and North America. BoneSupport is headquartered in Lund, Sweden.
Headquarters
Sweden
Address
Scheelevagen 19, Lund, 22370
Website
www.bonesupport.com
Telephone
46 46 2865370
No of Employees
98
Industry
Medical Equipment
Revenue (2020)
$32.5M
BoneSupport AB premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Vancomycin-Eluting Synthetic Bone Substitute | CERAMENT |
| Gentamicin Antibiotic Eluting Bone Graft Substitute | BONESUPPORT |
| Bone Void Filler |
Competitor Comparison
| Key Parameters | BoneSupport AB | Ossur hf | Promimic AB | DOT GmbH | Graftys SA |
|---|---|---|---|---|---|
| Headquarters | Sweden | Iceland | Sweden | Germany | France |
| City | Lund | Reykjavik | Moelndal | Rostock | Aix-en-Provence |
| State/Province | - | - | - | Mecklenburg-Vorpommern | Provence - Alpes- Cote d'Azur |
| No. of Employees | 98 | 3,866 | - | - | - |
| Entity Type | Private | Public | Public | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lennart Johansson | Chairman | Executive Board | 2017 | 68 |
| Emil Billback | Chief Executive Officer | Senior Management | 2018 | 53 |
| Hakan Johansson | Chief Financial Officer | Senior Management | 2018 | 60 |
| Michael Diefenbeck | Executive Vice President - Medical and Clinical Affairs; Chief Medical Officer | Senior Management | 2017 | 49 |
| Annelie Aava Vikner | Executive Vice President - Global Marketing | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer